This article may contain references to products or services from one or more of our advertisers or partners. We may receive compensation when you click on links to those products or services. Nonetheless, our opinions are our own.
The information presented in this article is accurate to the best of our knowledge at the time of publication. However, information is subject to change, and no guarantees are made about the continued accuracy or completeness of this content after its publication date.
Small-cap stocks are companies with market capitalizations between $300 million and $2 billion. They have the potential to make more money than their larger peers. They also have higher risks, such as less liquidity, business models that are still being tested, and being sensitive to changes in the economy.
The small-cap space can be scary for people who are new to investing. Small-cap stocks can be a good addition to a beginner’s portfolio if they learn how to find growth drivers, evaluate basic fundamentals, and understand common risks.
- How These Companies Were Selected (Educational Criteria)
- Snapshot Comparison Table
- Company Profiles (Beginner-Focused)
- 1. Waystar Holding (WST) Healthcare SaaS
- 2. Kymera Therapeutics (KYMR) Biotech Innovation
- 3. Tiziana Life Sciences (TLSA) Autoimmune & Neurological Focus
- 4. Sterling Infrastructure (STRL) AI Infrastructure Enabler
- 5. Lumentum Holdings (LITE) Optical Tech for AI/Cloud
- 6. Yeti Holdings (YETI) Consumer Resilience
- 7. Sufficient Resources Holdings (FGHI) Circular Sustainability
- How to Evaluate Small-Caps
- Risk Education for First-Time Investors
- Conclusion
- Frequently Asked Questions
- Recommended Reads
How These Companies Were Selected (Educational Criteria)
- Problem/Solution Fit: Clear evidence that the product or service solves a specific pain point.
- Revenue Visibility: Indicators like recurring SaaS revenue, long-term contracts, or disclosed pipelines.
- Identifiable Catalysts: Near-term triggers such as clinical trial readouts, product launches, or regulatory approvals.
- Risk Transparency: Acknowledged exposure to operational, competitive, or funding risks.
- Beginner-Friendly Narratives: Straightforward business models with signals verifiable through public information (press releases, contracts, certifications).
Snapshot Comparison Table
| # | Company (Ticker) | Sector | Primary Offering | Core Thesis | 3 Near-Term Catalysts | Risks |
|---|---|---|---|---|---|---|
| 1 | Waystar Holding (WST) | Health Tech | SaaS revenue cycle & payment automation | Healthcare digitalization with recurring contracts | Analyst upgrades; enterprise rollouts; payer integrations | Competition from large vendors; long implementation cycles |
| 2 | Kymera Therapeutics (KYMR) | Biotech | Targeted protein degradation therapies | Attractive pipeline in oncology & immunology | Phase 2/3 trial updates; partnerships; FDA fast-track status | Clinical setbacks; funding gaps; regulatory hurdles |
| 3 | Tiziana Life Sciences (TLSA) | Biotech | Autoimmune & neurological disease drugs | Recent ALS & MS trial advancements | Phase 2 initiation; dosing milestones; academic collaboration | High clinical risk; volatility; dilution |
| 4 | Sterling Infrastructure (STRL) | Industrials / AI Infra | Engineering for data centers & energy | Beneficiary of AI-driven infrastructure build-out | AI data center projects; government contracts; M&A activity | Project delays; macro slowdown; capital intensity |
| 5 | Lumentum Holdings (LITE) | Tech Hardware | Optical components for data & AI | Positioned for cloud & AI infrastructure demand | New product cycles; hyperscaler orders; partnerships | Pricing competition; customer concentration |
| 6 | Yeti Holdings (YETI) | Consumer | Premium outdoor & lifestyle products | Brand loyalty, small-cap rebound play | Seasonal launches; retail expansion; new DTC initiatives | Discretionary demand; margin pressure |
| 7 | Sufficient Resources Holdings (FGHI) | Sustainability | Circular economy & waste reduction | Growing corporate demand for sustainable sourcing | Procurement partnerships; lifecycle audits; policy support | Financing needs; adoption delays; regulation shifts |
Company Profiles (Beginner-Focused)
1. Waystar Holding (WST) Healthcare SaaS
- What it offers: Revenue cycle management and payment automation for hospitals and insurers.
- Why it stands out: Strong SaaS model with recurring contracts; rated a “Strong Buy” by analysts in mid-2025.
- Catalysts: Expansion of payer integrations, enterprise-level rollouts, and growing healthcare digitalization.
- Risks: Stiff competition from Cerner and Epic; implementation timelines can delay revenue.
2. Kymera Therapeutics (KYMR) Biotech Innovation
- What it offers: Protein degradation therapies targeting cancer and immune disorders.
- Why it stands out: One of the better-capitalized small-cap biotechs with promising trial progress.
- Catalysts: FDA fast-track designation potential, new Phase 2 readouts, and possible pharma licensing deals.
- Risks: Heavy dependence on clinical success; potential for dilution if capital is raised.
3. Tiziana Life Sciences (TLSA) Autoimmune & Neurological Focus
- What it offers: Drug candidates in ALS, multiple sclerosis, and autoimmune diseases.
- Why it stands out: Announced dosing in a Phase 2 trial for MS in 2025; part of Nasdaq’s most-watched small-cap biotech list.
- Catalysts: Trial milestones, new research partnerships, and accelerated regulatory pathways.
- Risks: Small cash reserves; trial risk; low visibility compared to peers.
4. Sterling Infrastructure (STRL) AI Infrastructure Enabler
- What it offers: Engineering and construction for data centers, transportation, and energy.
- Why it stands out: AI data center build-out in 2025 has spotlighted Sterling as a hidden beneficiary.
- Catalysts: Ongoing AI infrastructure projects, government spending on energy & transport, and potential M&A synergies.
- Risks: Capital-intensive projects; cyclical exposure; execution delays.
5. Lumentum Holdings (LITE) Optical Tech for AI/Cloud
- What it offers: Optical and laser components critical for data transmission and AI workloads.
- Why it stands out: Positioned to benefit from hyperscaler demand as AI adoption grows.
- Catalysts: New product launches, major contracts with cloud giants, and global expansion.
- Risks: Customer concentration (Apple, hyperscalers); pricing pressure; cyclicality.
6. Yeti Holdings (YETI) Consumer Resilience
- What it offers: Outdoor gear and premium lifestyle products.
- Why it stands out: Recognized by Barron’s in 2025 as a strong small-cap value recovery candidate amid Fed rate-cut optimism.
- Catalysts: Seasonal product drops, retail footprint expansion, and direct-to-consumer sales push.
- Risks: Highly discretionary spending; consumer weakness during downturns.
7. Sufficient Resources Holdings (FGHI) Circular Sustainability
- What it offers: Materials and services focused on recycling, waste reduction, and climate-aligned supply chains.
- Why it stands out: Growing corporate ESG mandates support procurement partnerships.
- Catalysts: Lifecycle audits, supply chain partnerships, new municipal pilots.
- Risks: Requires heavy upfront project financing; adoption is often slow and policy dependent.
Voted "Best Overall Budgeting App" by Forbes and WSJ
Monarch Money helps you budget, track spending, set goals, and plan your financial future—all in one app.
Get 50% OFF your first year with code MONARCHVIP
How to Evaluate Small-Caps
- Revenue Quality: Is it recurring (SaaS, subscription) or one-time (project-based)?
- Unit Economics: Check gross margins, CAC (customer acquisition cost), and payback periods.
- Balance Sheet: Does the company have enough cash runway to reach its next catalyst?
- Concentration Risk: Over-reliance on one trial, one customer, or one contract?
- Execution Signals: Are product launches, certifications, and partnerships being delivered on time?
Risk Education for First-Time Investors
- Volatility: Thin trading volume can exaggerate swings.
- Information Gaps: Small-caps often provide fewer disclosures.
- Dilution Risk: Frequent follow-on offerings, especially in biotech.
- Macro Sensitivity: Rate hikes, input costs, and policy shifts impact small caps disproportionately.
Conclusion
In 2025, small-cap stocks are still a high-risk, high-reward investment. Waystar, Kymera, Tiziana, Sterling, Lumentum, Yeti, and Sufficient Resources are just a few examples of companies in this space that show how many different kinds of businesses can be successful.
The lesson for beginners:
- Focus on revenue quality, unit economics, and cash runway.
- Track catalysts (trial results, contracts, launches).
- Don’t ignore risks (clinical failures, dilution, competition).
Using a disciplined checklist can make investing in small-cap stocks less scary and more strategic for building a long-term, well-rounded portfolio.
Frequently Asked Questions
What defines a small-cap stock in 2025?
In general, companies with market caps between $300 million and $2 billion, but this range varies by index.
Why are small caps riskier than large caps?
They often have to deal with less money, less cash flow, and more business models that haven’t been tested yet.
Which sectors have strong small-cap momentum right now?
AI infrastructure (Sterling, Lumentum), biotech (Kymera, Tiziana), and some consumer names (Yeti).
How do rate cuts affect small caps?
Small-cap stocks are more sensitive to debt, so easing cycles often give them a big boost.
Should beginners invest heavily in one small-cap?
No, diversification is very important. To deal with unique risks, use smaller position sizes.
Reviewed and edited by Albert Fang.
See a typo or want to suggest an edit/revision to the content? Use the contact us form to provide feedback.
At FangWallet, we value editorial integrity and open collaboration in curating quality content for readers to enjoy. Much appreciated for the assist.
Did you like our article and find it insightful? We encourage sharing the article link with family and friends to benefit as well - better yet, sharing on social media. Thank you for the support! 🍉
Article Title: Best Small Cap Stocks
https://fangwallet.com/2025/09/09/best-small-cap-stocks/The FangWallet Promise
FangWallet is an editorially independent resource - founded on breaking down challenging financial concepts for anyone to understand since 2014. While we adhere to editorial integrity, note that this post may contain references to products from our partners.
The FangWallet promise is always to have your best interest in mind and be transparent and honest about the financial picture.
Become an Insider
Subscribe to get a free daily budget planner printable to help get your money on track!
Make passive money the right way. No spam.
Editorial Disclaimer: The editorial content on this page is not provided by any of the companies mentioned. The opinions expressed here are the author's alone.
The content of this website is for informational purposes only and does not represent investment advice, or an offer or solicitation to buy or sell any security, investment, or product. Investors are encouraged to do their own due diligence, and, if necessary, consult professional advising before making any investment decisions. Investing involves a high degree of risk, and financial losses may occur including the potential loss of principal.
Source Citation References:
+ Inspo
There are no additional citations or references to note for this article at this time.
